Switzerland, US in agreement on pharma GMP
Under the agreement, both countries will be able to utilise each other’s GMP inspections of pharmaceutical manufacturing facilities, avoiding the need for duplicate inspections
MRA | 19/01/2023 | By Sudeep Soparkar | 484
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy